Rules and Regulations

Latest Issue of OR Manager
May 2025
Home Regulations/Legal > Rules and Regulations

37% of aspiring nurses in fraudulent degree scheme passed NCLEX

Editor's Note The New York Times on January 27 reported that 37% of aspiring nurses who allegedly purchased fraudulent degrees to bypass coursework and training required to sit for the National Council Licensure Examination (NCLEX) passed the test. Many of the 7,600 individuals who paid between $10,000 and $15,000 for…

Read More

By: Judy Mathias
February 1, 2023
Share

COVID-19 national, public health emergencies to end May 11

Editor's Note The Biden administration announced on January 30 that it will end the COVID-19 national and public health emergencies on May 11, the January 31 APnews reports. The move gives healthcare providers and other stakeholders about 100 days to prepare for the termination. The national and public health emergencies…

Read More

By: Judy Mathias
January 31, 2023
Share

FDA proposes individual risk assessment for donating blood

Editor's Note The Food and Drug Administration (FDA) on January 27 announced that it is proposing to ease blood donation restrictions by focusing on behavior rather than gender and sexual identity. Under current rules, the FDA allows donations from gay and bisexual men if they haven’t had sex with another…

Read More

By: Judy Mathias
January 31, 2023
Share

State Boards of Nursing investigating fraudulent degrees

Editor's Note State Boards of Nursing are investigating those who allegedly bought fraudulent nursing degrees and diplomas as part of a widespread scheme to fast-track the process to take the National Council Licensure Examination, the January 27 Becker’s Hospital Review reports. Twenty-five individuals have been charged by the Justice Department…

Read More

By: Judy Mathias
January 30, 2023
Share

Sponsored Message

New CDC dashboards track hospitalizations for COVID-19, flu, RSV

Editor's Note The Centers for Disease Control and Prevention (CDC) is hosting a new dashboard—Respiratory Virus Hospitalization Surveillance Network (RESP-NET)—that tracks hospitalization rates for laboratory-confirmed COVID-19, influenza, and Respiratory Syncytial Virus (RSV) by age, sex, race/ethnicity, state, and season. The information is based on data from a network of acute…

Read More

By: Judy Mathias
January 23, 2023
Share

AAMI updates PPE standard

Editor's Note The Association for the Advancement of Medical Instrumentation (AAMI) on January 18 released a revised American National Standard that includes new information for manufacturers and users of personal protective equipment (PPE). The new edition of “ANSI/AAMI PB70:2022, Liquid barrier performance and classification of protective apparel and drapes intended…

Read More

By: Judy Mathias
January 19, 2023
Share

Sponsored Message

ASA updates preop fasting guidelines

Editor's Note The American Society of Anesthesiologists (ASA) has updated its 2017 guidelines for preoperative fasting and the use of pharmacologic agents to reduce the risk of pulmonary aspiration. The new 2023 guidance focuses on topics not addressed in the previous guideline, including ingestion of carbohydrate-containing clear liquids with or…

Read More

By: Judy Mathias
January 18, 2023
Share

FDA issues warning letters to endoscope manufacturer

Editor's Note The Food and Drug Administration (FDA) on January 10 announced that it had recently issued two warning letters to Olympus Medical Systems Corporation and one of its subsidiaries, Aizu Olympus Co, Ltd, after facility inspections. The letters addressed violations related to medical device reporting (MDR) requirements and quality…

Read More

By: Judy Mathias
January 12, 2023
Share

The Joint Commission raises healthcare equity standard to NPSG

Editor's Note The Joint Commission on January 10 announced that it had elevated the Leadership (LD) Standard LD.04.03.08, which addresses healthcare disparities as a quality and safety priority, to a National Patient Safety Goal (NPSG), effective July 1, 2023. Current requirements for accreditation will not change, and the intent behind…

Read More

By: Judy Mathias
January 11, 2023
Share

FDA: Class I recall of Arrow central venous access and catheter kits

Editor's Note The Food and Drug Administration (FDA) on December 16 identified the recall by Teleflex and Arrow International, LLC, of its Arrow MAC Two-Lumen Central Venous Access Kits and Arrow Pressure Injectable Arrowg+ard Blue Plus Three-Lumen Central Venous Catheter (CVC) Kits as Class I, the most serious. The recall…

Read More

By: Judy Mathias
January 4, 2023
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat